Cargando…

The risk to relatives of patients with sporadic amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a neurodegenerative disease of motor neurons with a median survival of 2 years. Most patients have no family history of amyotrophic lateral sclerosis, but current understanding of such diseases suggests there should be an increased risk to relatives. Furthermore, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanby, Martha F., Scott, Kirsten M., Scotton, William, Wijesekera, Lokesh, Mole, Thomas, Ellis, Catherine E., Nigel Leigh, P., Shaw, Christopher E., Al-Chalabi, Ammar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235555/
https://www.ncbi.nlm.nih.gov/pubmed/21933809
http://dx.doi.org/10.1093/brain/awr248
_version_ 1782218619010154496
author Hanby, Martha F.
Scott, Kirsten M.
Scotton, William
Wijesekera, Lokesh
Mole, Thomas
Ellis, Catherine E.
Nigel Leigh, P.
Shaw, Christopher E.
Al-Chalabi, Ammar
author_facet Hanby, Martha F.
Scott, Kirsten M.
Scotton, William
Wijesekera, Lokesh
Mole, Thomas
Ellis, Catherine E.
Nigel Leigh, P.
Shaw, Christopher E.
Al-Chalabi, Ammar
author_sort Hanby, Martha F.
collection PubMed
description Amyotrophic lateral sclerosis is a neurodegenerative disease of motor neurons with a median survival of 2 years. Most patients have no family history of amyotrophic lateral sclerosis, but current understanding of such diseases suggests there should be an increased risk to relatives. Furthermore, it is a common question to be asked by patients and relatives in clinic. We therefore set out to determine the risk of amyotrophic lateral sclerosis to first degree relatives of patients with sporadic amyotrophic lateral sclerosis attending a specialist clinic. Case records of patients with sporadic amyotrophic lateral sclerosis seen at a tertiary referral centre over a 16-year period were reviewed, and pedigree structures extracted. All individuals who had originally presented with sporadic amyotrophic lateral sclerosis, but who subsequently had an affected first degree relative, were identified. Calculations were age-adjusted using clinic population demographics. Probands (n = 1502), full siblings (n = 1622) and full offspring (n = 1545) were identified. Eight of the siblings and 18 offspring had developed amyotrophic lateral sclerosis. The unadjusted risk of amyotrophic lateral sclerosis over the observation period was 0.5% for siblings and 1.0% for offspring. Age information was available for 476 siblings and 824 offspring. For this subset, the crude incidence of amyotrophic lateral sclerosis was 0.11% per year (0.05–0.21%) in siblings and 0.11% per year (0.06–0.19%) in offspring, and the clinic age-adjusted incidence rate was 0.12% per year (0.04–0.21%) in siblings. By age 85, siblings were found to have an 8-fold increased risk of amyotrophic lateral sclerosis, in comparison to the background population. In practice, this means the risk of remaining unaffected by age 85 dropped from 99.7% to 97.6%. Relatives of people with sporadic amyotrophic lateral sclerosis have a small but definite increased risk of being affected.
format Online
Article
Text
id pubmed-3235555
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-32355552011-12-14 The risk to relatives of patients with sporadic amyotrophic lateral sclerosis Hanby, Martha F. Scott, Kirsten M. Scotton, William Wijesekera, Lokesh Mole, Thomas Ellis, Catherine E. Nigel Leigh, P. Shaw, Christopher E. Al-Chalabi, Ammar Brain Original Articles Amyotrophic lateral sclerosis is a neurodegenerative disease of motor neurons with a median survival of 2 years. Most patients have no family history of amyotrophic lateral sclerosis, but current understanding of such diseases suggests there should be an increased risk to relatives. Furthermore, it is a common question to be asked by patients and relatives in clinic. We therefore set out to determine the risk of amyotrophic lateral sclerosis to first degree relatives of patients with sporadic amyotrophic lateral sclerosis attending a specialist clinic. Case records of patients with sporadic amyotrophic lateral sclerosis seen at a tertiary referral centre over a 16-year period were reviewed, and pedigree structures extracted. All individuals who had originally presented with sporadic amyotrophic lateral sclerosis, but who subsequently had an affected first degree relative, were identified. Calculations were age-adjusted using clinic population demographics. Probands (n = 1502), full siblings (n = 1622) and full offspring (n = 1545) were identified. Eight of the siblings and 18 offspring had developed amyotrophic lateral sclerosis. The unadjusted risk of amyotrophic lateral sclerosis over the observation period was 0.5% for siblings and 1.0% for offspring. Age information was available for 476 siblings and 824 offspring. For this subset, the crude incidence of amyotrophic lateral sclerosis was 0.11% per year (0.05–0.21%) in siblings and 0.11% per year (0.06–0.19%) in offspring, and the clinic age-adjusted incidence rate was 0.12% per year (0.04–0.21%) in siblings. By age 85, siblings were found to have an 8-fold increased risk of amyotrophic lateral sclerosis, in comparison to the background population. In practice, this means the risk of remaining unaffected by age 85 dropped from 99.7% to 97.6%. Relatives of people with sporadic amyotrophic lateral sclerosis have a small but definite increased risk of being affected. Oxford University Press 2011-12 2011-09-20 /pmc/articles/PMC3235555/ /pubmed/21933809 http://dx.doi.org/10.1093/brain/awr248 Text en © The Author (2011). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hanby, Martha F.
Scott, Kirsten M.
Scotton, William
Wijesekera, Lokesh
Mole, Thomas
Ellis, Catherine E.
Nigel Leigh, P.
Shaw, Christopher E.
Al-Chalabi, Ammar
The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title_full The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title_fullStr The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title_full_unstemmed The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title_short The risk to relatives of patients with sporadic amyotrophic lateral sclerosis
title_sort risk to relatives of patients with sporadic amyotrophic lateral sclerosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235555/
https://www.ncbi.nlm.nih.gov/pubmed/21933809
http://dx.doi.org/10.1093/brain/awr248
work_keys_str_mv AT hanbymarthaf therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT scottkirstenm therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT scottonwilliam therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT wijesekeralokesh therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT molethomas therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT elliscatherinee therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT nigelleighp therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT shawchristophere therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT alchalabiammar therisktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT hanbymarthaf risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT scottkirstenm risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT scottonwilliam risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT wijesekeralokesh risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT molethomas risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT elliscatherinee risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT nigelleighp risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT shawchristophere risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis
AT alchalabiammar risktorelativesofpatientswithsporadicamyotrophiclateralsclerosis